Programs
Who It Is For
Getting Started
Cost and Coverage
Service Areas
Get in Touch
Resources
The semaglutide molecule
Explore how semaglutide works, what an assessment should cover and which questions to ask about the prescribed product. This Austin treatment guide explains the options; a healthcare professional must decide whether a prescription is appropriate.
How it works
Semaglutide activates GLP-1 receptors involved in regulating appetite and food intake. It can help reduce calorie intake by affecting hunger and fullness, and it also delays stomach emptying. The guide to how GLP-1 medicines work explains the wider mechanism. These effects help explain the treatment, but they do not predict an individual's weight change or establish that the medicine is suitable for them.
How you feel after starting matters alongside any change on the scale. The first month of GLP-1 treatment may bring changes in appetite or digestion that deserve discussion with the prescribing team. Review the guide to nausea and digestive symptoms, and ask which symptoms require a call or urgent assessment. Feeling unwell is not evidence that a dose is working better.
Reduced appetite still needs to leave room for adequate nourishment. Discuss nutrition during GLP-1 treatment, including any difficulty eating or drinking enough. The clinician can consider your response, other health needs and tolerability when reviewing treatment. Medication does not remove the need for appropriate food, activity and ongoing care.
Dosing
The starting dose is not a treatment dose. It exists so your body adjusts to the medication before the dose that does the work.
Increases happen at set intervals, typically every four weeks, and only when the current dose is tolerated.
If a step is not tolerated, holding or stepping back is standard. Almost everyone who has a miserable time went up too fast.
A dose that is effective and tolerable, held long term. Reaching it is the goal, not the highest number on the pen.
Who it suits
An assessment should establish the reason for considering semaglutide and the exact product proposed. Common adult weight-management criteria involve BMI requirements and, in some cases, weight-related health conditions. Those criteria are a starting point, not a prescription decision. The clinician also needs your treatment history, current health concerns and goals. Explain what you have tried, what made previous care difficult and which changes would matter in daily life.
Medical history can change the decision. The GLP-1 suitability guide introduces issues to review, including a personal or family history of medullary thyroid carcinoma or MEN2. These are specific conditions, not a shorthand for every thyroid problem. Discuss pregnancy intentions, breastfeeding and any previous serious reaction to treatment. Review prescriptions and supplements for possible semaglutide drug interactions as well. Your clinician should explain any reason to avoid a product, arrange further assessment or consider another approach before treatment begins.
Related
The brands semaglutide is sold under, and the molecule it competes with.
Common questions
The exact product, procedure planning, dose instructions and ongoing review all deserve clear answers.
The appetite change was noticeable in week two, well before anything showed on the scale. Being told to expect that order stopped me panicking.
The timing rules around food are strict and I nearly gave up. Once it became routine it was fine and I prefer it to injecting.
Held at the second dose for eight weeks instead of pushing on. That was the right call and it was their suggestion, not mine.
Fourteen months in on a maintenance dose. The plan for eventually coming off was discussed at month six rather than left hanging.
From the blog
Next step
Suitability turns on your conditions, your family history and what else you take. That is what the assessment establishes before anything is prescribed.
Licensed clinicians · Eligibility reviewed before any prescription · Virtual appointments